Deep learning of multi-omics data helps research and development of precision therapeutic drugs.

Aegicare is a genomic intelligence company empowering precision medicine, from high-throughput diagnosis to innovative therapeutics. With our first-in-class clinical lab and AEGIS genomic intelligence platform powered by cutting-edge natural language processing, bioinformatics, and deep learning algorithms, we make genetic information more affordable and accessible, we facilitate better clinical decisions, and we revolutionize the process for genome-based drug discovery. Nearly 4% of the world’s population are suffering from genetic diseases that do not have a cure, around 80~95% of people need to try multiple drugs in order to find one that’s effective, even more strikingly, millions of people have hospitalized annually due to adverse side effects from medications, resulting in hundreds of thousands of deaths per year. This highlights the critical need for precision medicine.